Potential future target for treating primary headache disorders identified
Researchers at Karolinska Institutet have identified an interesting potential future therapeutic target in primary headache disorders. They have found increased amounts of a gene associated with cluster headache, MERTK, and its ligand Gal-3, in tissue from cluster headache patients. Their study is published in the Journal of Headache and Pain.
Source: medicalxpress.com